{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:24:03Z","timestamp":1763000643184,"version":"3.45.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Update"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.tru.2021.100069","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T01:07:24Z","timestamp":1630631244000},"page":"100069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["\u201cPortal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome\u201d"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-1764","authenticated-orcid":false,"given":"Nikolaos","family":"Melas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"European Medicines Agency","key":"10.1016\/j.tru.2021.100069_bib1"},{"year":"2021","series-title":"COVID-19 Vaccine Frequently Asked Questions","author":"FDA","key":"10.1016\/j.tru.2021.100069_bib3"},{"key":"10.1016\/j.tru.2021.100069_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.tru.2021.100069_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J ThrombHaemost"},{"issue":"3","key":"10.1016\/j.tru.2021.100069_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11739-021-02685-0","article-title":"Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine","volume":"16","author":"Carli","year":"2021","journal-title":"Intern Emerg Med"},{"issue":"8","key":"10.1016\/j.tru.2021.100069_bib7","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","article-title":"Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine","volume":"30","author":"Dias","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.tru.2021.100069_bib8","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.932946","article-title":"A 59-year-old woman with extensive deep vein thrombosis and pulmonary thromboembolism 7 Days following a first dose of the pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine","volume":"22","author":"Al-Maqbali","year":"2021","journal-title":"Am J Case Rep"},{"year":"2021","series-title":"Benefits Still Outweigh the Risks Despite Possible Link to Rare Blood Clots with Low Blood Platelets","key":"10.1016\/j.tru.2021.100069_bib9"},{"key":"10.1016\/j.tru.2021.100069_bib10","first-page":"524","article-title":"Women's issues in antiphospholipid syndrome","volume":"18","author":"Papadakis","year":"2016","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.tru.2021.100069_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","article-title":"Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: the straw that breaks the camel's back?","volume":"60","author":"Talotta","year":"2021","journal-title":"Cytokine Growth Factor Rev."}],"container-title":["Thrombosis Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572721000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666572721000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:20:21Z","timestamp":1763000421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666572721000389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":10,"alternative-id":["S2666572721000389"],"URL":"https:\/\/doi.org\/10.1016\/j.tru.2021.100069","relation":{},"ISSN":["2666-5727"],"issn-type":[{"type":"print","value":"2666-5727"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cPortal vein thrombosis occurring after the first dose of mRNA SARS-CoV-2 vaccine in a patient with antiphospholipid syndrome\u201d","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Update","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tru.2021.100069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100069"}}